Viyash Scientific · NSE: VIYASH · BSE: 512529
Q2 FY25 results · Jul–Sep 2024
Viyash Scientific reported revenue from operations of ₹368.65 crore (up 6.6% from Q2 FY24) and net profit of ₹6.34 crore for Q2 FY25 (Jul–Sep 2024), on a consolidated basis.
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 368.65 | 345.97 | +6.6% | 390.21 | −5.5% |
| Other income | 4.51 | 1.65 | +173.7% | 2.68 | +68.3% |
| Total income | 373.16 | 347.62 | +7.3% | 392.89 | −5.0% |
| Profit before tax | 7.90 | (3.09) | Turned profit | 12.00 | −34.2% |
| Net profit for the period | 6.34 | (6.88) | Turned profit | 9.06 | −30.0% |
| EPS, basic (₹) | 0.10 | (0.34) | not comparable | 0.26 | −61.7% |
| Net margin (%) | 1.7 | -2.0 | 2.3 |
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 41.99 | 49.12 | −14.5% | 57.67 | −27.2% |
| Other income | 15.95 | 9.87 | +61.7% | 10.84 | +47.1% |
| Total income | 57.94 | 58.98 | −1.8% | 68.51 | −15.4% |
| Profit before tax | 6.41 | (1.40) | Turned profit | 6.05 | +6.0% |
| Net profit for the period | 4.26 | (0.92) | Turned profit | 4.50 | −5.3% |
| EPS, basic (₹) | 0.17 | (0.04) | Turned profit | 0.18 | −5.6% |
| Net margin (%) | 10.1 | -1.9 | 7.8 |
Consolidated
- Filed with BSE
- 14 Nov 2024, 12:04 IST
- Board meeting
- 13 Nov 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 14 Nov 2024, 12:04 IST
- Board meeting
- 13 Nov 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE